The trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats

Neuroscience Letters

Volumn 566, Issue , 2014, Pages 67-71

  Thorn, David A ^a   Zhang, Chaogui ^b   Zhang, Yanan ^c   Li, Jun Xu ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b HUBEI UNIVERSITY FOR NATIONALITIES   (China)

^c RTI INTERNATIONAL   (United States)

Author keywords

Behavioral sensitization; Cocaine; Rats; TAAR 1

Indexed keywords

AMINE; DRUGS USED IN THE TREATMENT OF ADDICTION; RO 5263397; TRACE AMINE ASSOCIATED RECEPTOR 1 AGONIST; UNCLASSIFIED DRUG;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DRUG ADMINISTRATION; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; HYPERACTIVITY; LOCOMOTION; MALE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RESEARCH; RODENT MODEL; SENSITIZATION;

BEHAVIORAL SENSITIZATION; COCAINE; RATS; TAAR 1;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COCAINE-RELATED DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84896090771     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.02.024     Document Type: Article

References (25)

1. Achat-Mendes C., Lynch L.J., Sullivan K.A., Vallender E.J., Miller G.M. Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1. Pharmacol. Biochem. Behav. 2012, 101:201-207.
2. Baladi M.G., Koek W., Aumann M., Velasco F., France C.P. Eating high fat chow enhances the locomotor-stimulating effects of cocaine in adolescent and adult female rats. Psychopharmacology (Berl.) 2012, 222:447-457.
3. Barger G., Dale H.H. Chemical structure and sympathomimetic action of amines. J. Physiol. 1910, 41:19-59.
4. Borowsky B., Adham N., Jones K.A., Raddatz R., Artymyshyn R., Ogozalek K.L., Durkin M.M., Lakhlani P.P., Bonini J.A., Pathirana S., Boyle N., Pu X., Kouranova E., Lichtblau H., Ochoa F.Y., Branchek T.A., Gerald C. Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:8966-8971.
5. Bradaia A., Trube G., Stalder H., Norcross R.D., Ozmen L., Wettstein J.G., Pinard A., Buchy D., Gassmann M., Hoener M.C., Bettler B. The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20081-20086.
6. Bunzow J.R., Sonders M.S., Arttamangkul S., Harrison L.M., Zhang G., Quigley D.I., Darland T., Suchland K.L., Pasumamula S., Kennedy J.L., Olson S.B., Magenis R.E., Amara S.G., Grandy D.K. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol. Pharmacol. 2001, 60:1181-1188.
7. Grandy D.K. Trace amine-associated receptor 1-Family archetype or iconoclast?. Pharmacol. Ther. 2007, 116:355-390.
8. Li J.X., Han R., Deng Y.P., Chen S.Q., Liang J.H. Different effects of valproate on methamphetamine- and cocaine-induced behavioral sensitization in mice. Behav. Brain Res. 2005, 161:125-132.
9. Li J.X., Shah A.P., Patel S.K., Rice K.C., France C.P. Modification of the behavioral effects of morphine in rats by serotonin 5-HT(1)A and 5-HT(2)A receptor agonists: antinociception, drug discrimination, and locomotor activity. Psychopharmacology (Berl.) 2013, 225:791-801.
10. Li J.X., Thorn D.A., Jin C. The GPR88 receptor agonist 2-PCCA does not alter the behavioral effects of methamphetamine in rats. Eur. J. Pharmacol. 2013, 698:272-277.
11. Li J.X., Zhang Q., Liang J.H. Valproate prevents the induction, but not the expression of morphine sensitization in mice. Behav. Brain Res. 2004, 152:251-257.
12. Li J.X., Zhao W.L., Liang J.H. Effects of carbamazepine on morphine-induced behavioral sensitization in mice. Brain Res. 2004, 1019:77-83.
13. Lindemann L., Meyer C.A., Jeanneau K., Bradaia A., Ozmen L., Bluethmann H., Bettler B., Wettstein J.G., Borroni E., Moreau J.L., Hoener M.C. Trace amine-associated receptor 1 modulates dopaminergic activity. J. Pharmacol. Exp. Ther. 2008, 324:948-956.
14. Lynch L.J., Sullivan K.A., Vallender E.J., Rowlett J.K., Platt D.M., Miller G.M. Trace amine associated receptor 1 modulates behavioral effects of ethanol. Subst. Abuse 2013, 7:117-126.
15. McGuire B.A., Baladi M.G., France C.P. Eating high-fat chow enhances sensitization to the effects of methamphetamine on locomotion in rats. Eur. J. Pharmacol. 2011, 658:156-159.
16. Revel F.G., Meyer C.A., Bradaia A., Jeanneau K., Calcagno E., Andre C.B., Haenggi M., Miss M.T., Galley G., Norcross R.D., Invernizzi R.W., Wettstein J.G., Moreau J.L., Hoener M.C. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine. Neuropsychopharmacology 2012, 37:2580-2592.
17. Revel F.G., Moreau J.L., Gainetdinov R.R., Bradaia A., Sotnikova T.D., Mory R., Durkin S., Zbinden K.G., Norcross R., Meyer C.A., Metzler V., Chaboz S., Ozmen L., Trube G., Pouzet B., Bettler B., Caron M.G., Wettstein J.G., Hoener M.C. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:8485-8490.
18. Revel F.G., Moreau J.L., Gainetdinov R.R., Ferragud A., Velazquez-Sanchez C., Sotnikova T.D., Morairty S.R., Harmeier A., Groebke Zbinden K., Norcross R.D., Bradaia A., Kilduff T.S., Biemans B., Pouzet B., Caron M.G., Canales J.J., Wallace T.L., Wettstein J.G., Hoener M.C. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biol. Psychiatry 2012, 72:934-942.
19. Revel F.G., Moreau J.L., Pouzet B., Mory R., Bradaia A., Buchy D., Metzler V., Chaboz S., Groebke Zbinden K., Galley G., Norcross R.D., Tuerck D., Bruns A., Morairty S.R., Kilduff T.S., Wallace T.L., Risterucci C., Wettstein J.G., Hoener M.C. A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight. Mol. Psychiatry 2013, 18:543-556.
20. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 1993, 18:247-291.
21. Sampson C., Zhang Y., Del Bello F., Li J.X. Effects of imidazoline I2 receptor ligands on acute nociception in rats. Neuroreport 2012, 23:73-77.
22. Steketee J.D., Kalivas P.W. Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol. Rev. 2011, 63:348-365.
23. Thorn D.A., An X.F., Zhang Y., Pigini M., Li J.X. Characterization of the hypothermic effects of imidazoline I(2) receptor agonists in rats. Br. J. Pharmacol. 2012, 166:1936-1945.
24. Wolinsky T.D., Swanson C.J., Smith K.E., Zhong H., Borowsky B., Seeman P., Branchek T., Gerald C.P. The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav. 2007, 6:628-639.
25. Xie Z., Miller G.M. Trace amine-associated receptor 1 as a monoaminergic modulator in brain. Biochem. Pharmacol. 2009, 78:1095-1104.